Balchem (BCPC) Akcie Kurz
Balchem Kurz
Za posledních 19 let vzrostly tržby Balchem o 13,0 % ročně a dosáhly 1,04 Mld. USD. Zisk na akcii rostl o 13,2 % ročně za posledních 19 let. U Balchem je čistá marže 14,9 % nahoru oproti 12,0 % před několika lety. Při dnešní ceně vychází dividendový výnos zhruba na 0,55 %. Výplatní poměr je kolem 20 % zisku. Dividenda rostla o 15,7 % ročně za posledních 19 let. Konsenzuální 12měsíční cílová cena pro Balchem je 215,00 USD, asi nad cenu o 22,5 %. Z 10 analytiků jich 8 doporučuje nákup — celkový konsenzus je Koupit.
Cena akcie Balchem
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Balchem a analýza akcií
Nejčastější otázky týkající se akcie Balchem
Balchem Corp is a leading company with a unique business model. The company specializes in the development, manufacturing, and marketing of specialty performance ingredients and products, catering to various industries. Balchem Corp focuses on providing innovative solutions that enhance the health and well-being of people, animals, and plants. With a diverse portfolio, the company offers nutritional, flavor, and fragrance ingredients, as well as animal health products and specialty film solutions. Balchem Corp consistently aims to deliver high-quality products and services that meet the evolving needs of its customers, reinforcing its position as a trusted industry leader.
Balchem Corp is primarily active in the industries of nutrition and health, animal nutrition, specialty products, and industrial products.
The main competitors of Balchem Corp in the market include companies such as Archer Daniels Midland Company, Innophos Holdings Inc., and Corbion N.V.
Balchem Corp is a leading company in the specialty chemicals industry. Founded in 1967, Balchem Corp has established a strong reputation for delivering innovative solutions across various sectors including human and animal nutrition, food and beverage, and pharmaceuticals. The company's rich history spans over five decades, marked by continuous growth and strategic acquisitions. Balchem Corp remains committed to providing high-quality products and services, leveraging its expertise in encapsulation, chelation, and controlled release technologies. With a customer-centric approach and a focus on sustainable solutions, Balchem Corp continues to drive forward in its mission to enhance health and well-being through its diverse portfolio of products and cutting-edge research.
Balchem Corp has achieved several significant milestones in its history. One of the key milestones is its acquisition of certain assets of Animal Nutrition & Health (ANH) business from a leading global food company, AkzoNobel, in 2012. This acquisition allowed Balchem to expand its portfolio and become a leading provider of encapsulated nutraceuticals for both human and animal health markets. Additionally, the company has consistently demonstrated strong financial performance over the years, with increasing revenues and earnings. Furthermore, Balchem has established itself as a trusted name in the industry, known for its high-quality products and innovative solutions.
Balchem Corp is primarily present in the United States.
Balchem Corp represents a commitment to innovation, sustainability, and to making a positive impact in the industries it serves. The company focuses on delivering high-quality, science-based solutions that provide unique value to its customers. Balchem Corp places a strong emphasis on corporate responsibility, striving to operate in a socially and environmentally responsible manner. With a dedicated team and a customer-centric approach, the company aims to consistently provide exceptional products and services that meet the evolving needs of its clients.
Analytici aktuálně stanovují průměrnou cílovou cenu 215,00 USD pro akcii Balchem (medián: 215,00 USD), tedy +22,5 % vůči poslední ceně. Konsensus vychází z 10 hodnocení analytiků.
10 analytiků aktuálně hodnotí akcii Balchem: 8 doporučuje koupit, 2 držet a 0 prodat. Pro rok 2026 analytici očekávají u Balchem tržby 1,13 Mld. USD a zisk na akcii 5,53 USD.
Při aktuálním kurzu se akcie Balchem obchoduje za 156,81 EUR (175,51 USD).
Akcie Balchem (BCPC) je kótována na 5 burzách, mimo jiné: NASDAQ (BCPC), SIX (Zürich) (BL9B.SW), Frankfurt (BL9B.F), München (BL9B.MU), Düsseldorf (BL9B.DU).
Balchem Corp is a leading company in the fields of animal nutrition, human nutrition, and industrial chemicals. The innovative company offers a wide range of products and solutions tailored to the needs of its customers. Balchem's animal nutrition division provides solutions for animal feed enhancement, health, and well-being of livestock, pets, and aquaculture. Balchem's products help animal owners improve the health of their animals and increase growth and productivity. Balchem uses innovative technologies to offer its customers powerful and effective feed enhancement solutions that provide significant benefits for animal health and performance. Balchem's human nutrition division offers solutions tailored to the health and needs of the modern consumer. Balchem's products include functional ingredients, vitamins, minerals, and amino acids used in food, beverages, supplements, and pharmaceutical products. Balchem aims to improve human health and well-being by offering innovative products that help consumers maximize their health and happiness. Balchem's industrial chemicals division offers a variety of solutions for applications in agriculture, industry, and other industries. Balchem produces and distributes chemicals that can be used for many different purposes, including pesticides, defoliants, flame retardants, and many more. Balchem leverages its experience and expertise in the chemical industry to offer innovative solutions to its customers, helping them achieve their business goals. An example of a Balchem product is Choline Chloride, which is known as an essential nutrient for animals. It supports the growth and maintenance of cells and tissues, especially the nervous system. It is necessary for the synthesis of lecithin, which is an important component of any cell membrane. Overall, Balchem's business model is based on providing innovative, customer-oriented solutions tailored to the needs of its customers. The company has a strong focus on research and development of new products and technologies, which allows it to continuously enter new markets and remain competitive. By continuously evolving high-quality products and services, Balchem creates value for its customers and supports them in achieving their goals.
Tržby očekávané za Balchem činí 1,13 Mld. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk očekávané za Balchem činí 178,67 Mil. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Balchem je aktuálně 31,75. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Balchem.
Poměr ceny k tržbám (P/S) Balchem je aktuálně 5,01. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Balchem.
Score kvality pro Balchem je 6/10.
ISIN Balchem je US0576652004. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Balchem je 905650. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Balchem je BCPC. Symbol tickeru se používá k obchodování akcií Balchem na burze.
Balchem akcie
Balchem Peer Group
Balchem Ticker
Balchem FIGI
Všechny fundamentální údaje o Balchem v podrobné analýze
Naše analýzy akcií společnosti Balchem zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Balchem. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: